Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide corresponding to a region within amino acids 693 and 757 of Human GPCR LGR7|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-28759 targets GPCR LGR7 in WB applications and shows reactivity with Human samples.
The PA5-28759 immunogen is synthetic peptide corresponding to a region within amino acids 693 and 757 of Human GPCR LGR7.
Receptor for relaxins. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. Binding of the ligand may also activate a tyrosine kinase pathway that inhibits the activity of a phosphodiesterase that degrades cAMP.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
leucine-rich repeat-containing G protein-coupled receptor 7; LGR7; relaxin receptor 1; relaxin/insulin-like family peptide receptor 1; RXFPR1
LGR7; RXFP1; RXFPR1